The correlation of angiogenesis with metastasis in primary cutaneous melanoma: a comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor

References

• Rak J., Filmus J., Kerbel R. S. reciprocal paracrine ınteractions between tumour cells and endothelial cells: the ‘angiogenesis progression’ hypothesis. Eur J Cancer 1996; 32A: 2438–50
   PubMed Web of Science ®Google Scholar
• Marcoval J., Moreno A., Graells J., et al. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J Cutan Pathol 1997; 24: 212–8
   PubMed Web of Science ®Google Scholar
• Potti A., Moazzam N., Tendulkar K., Javed N. A., Koch M., Kargas S. Immunohistochemical Determination of vascular endothelial growth factor (vEGF) overexpression in malignant melanoma. Anticancer Res 2003; 23: 4023–6
   PubMed Web of Science ®Google Scholar
• Takahashi Y., Tucker S. L., Kitadai Y., et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node‐negative colon cancer. Arch Surg 1997; 132: 541–6
   PubMed Web of Science ®Google Scholar
• Fallowfield M. E., Cook M. G. The vascularity of primary cutaneous melanoma. J Pathol 1991; 164: 241–4
   PubMed Web of Science ®Google Scholar
• Srivastava A., Laidler P., Hughes L. E., Woodcock J., Shedden E. J. Neovascularisation in human cutaneous melanoma: a quantitative morphological and doppler ultrasound study. Eur J Cancer Clin Oncol 1986; 22: 1205–9
   PubMedGoogle Scholar
• Neitzel L. T., Neitzel C. D., Magee K. L., Malafa M. P. Angiogenesis correlates with metastasis in melanoma. Ann Surg Oncol 1999; 6: 70–4
   PubMed Web of Science ®Google Scholar
• Srivastava A., Laidler P., Davies R., Horgan K., Hughes L. E. The prognostic significance of tumor vascularity in ıntermediate‐thickness (0.76–4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 1988; 133: 419–23
   PubMed Web of Science ®Google Scholar
• Ribatti D., Vacca A., Palma W., Lospalluti M., Dammacco F. Angiogenesis during tumor progression in human malignant melanoma. EXS 1992; 61: 415–20
   PubMedGoogle Scholar
• Barnhill R. L., Fandrey K., Levy M. A., Mihm M., Hyman B. Angiogenesis and tumor progression of melanoma. quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest 1992; 67: 331–7
   PubMed Web of Science ®Google Scholar
• Busam K. J., Berwick M., Blessing K., et al. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995; 147: 1049–56
   PubMed Web of Science ®Google Scholar
• Vacca A., Ribatti D., Roncali L., et al. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67‐kilodalton laminin receptor. Cancer 1993; 72: 455–61
   PubMed Web of Science ®Google Scholar
• Cockerell C. J., Sonnier G., Kelly L., Patel S. Comparative analysis of neovascularization in primary cutaneous melanoma and spitz nevus. Am J Dermatopathol 1994; 16: 9–13
   PubMed Web of Science ®Google Scholar
• Carnochan P., Briggs J. C., Westbury G., Davies A. J. S. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85–1.25 mm in thickness. Br J Cancer 1991; 64: 102–7
   PubMed Web of Science ®Google Scholar
• Graham C. H., Rivers J., Kerbel R. S., Stamkiewicz K. S., White W. L. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol 1994; 145: 510–4
   PubMed Web of Science ®Google Scholar
• Salven P., Heikkila P., Joensuu H. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer 1997; 76: 930–4
   PubMed Web of Science ®Google Scholar
• Al‐Alousi S., Barnhill R., Blessing K., Barksdale S. The prognostic significance of basic fibroblast growth factor in cutaneous malignant melanoma. J Cutan Pathol 1996; 23: 506–10
   PubMed Web of Science ®Google Scholar
• Horak E. R., Leek R., Klenk N., et al. Angiogenesis, assessed by platelet/endotelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992; 340: 1120–4
   PubMed Web of Science ®Google Scholar
• Rongioletti F., Miracco C., Gambini C., Pastorino A., Tosi P., Rebora A. Tumor vascularity as a prognostic indicator in intermediate‐thickness (0.76–4 mm) cutaneous melanoma. Am J Dermatol 1996; 18: 474–7
   Web of Science ®Google Scholar
• Claffey K. P., Brown L. F., del Aguila L. F., et al. Expression of vascular permability factor/vascular endothelial growth factor by melanoma cells ıncreases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996; 56: 172–81
   PubMed Web of Science ®Google Scholar
• Goydos J. S., Gorski D. H. Vascular endothelial growth factor C mRNA expression correlates with stages of progression in patients with melanoma. Clin Cancer Res 2003; 9: 5962–7
   PubMed Web of Science ®Google Scholar
• Redondo P., Sanchez‐Carpintero I., Bauza A., Idoate M., Solano T., Mihm M. Immunologic escape and angiogenesis in human malignant melanoma. J Am Acad Dermatol 2003; 49: 255–63
   PubMed Web of Science ®Google Scholar
• Pötgens A. J., Lubsen N. H., Van Altena M. C., Schoenmaakers J. G. G., Ruiter D. J., de Waal R. M. W. Vascular permeability factor expression ınfluences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am J Pathol 1995; 146: 197–209
   PubMed Web of Science ®Google Scholar
• Halaban R. Growth factors and tyrosine protein kinases in normal and malignant melanocytes. Cancer Metastasis Rev 1991; 10: 129–40
   PubMed Web of Science ®Google Scholar
• Schulze‐Osthoff K., Risau W., Vollmer E., Sorg C. In situ detection of bFGF by highly specific antibodies. Am J Pathol 1990; 137: 85–92
   PubMed Web of Science ®Google Scholar
• Meier F., Nesbit M., Hsu M. Y., et al. Human melanoma progression in skin reconstructs. Biological significance of bFGF. Am J Pathol 2000; 156: 193–9
   PubMed Web of Science ®Google Scholar
• Ribatti D., Vacca A., Ria R., et al. Neovascularisation, expression of fibroblast growth factor‐2, and mast cells with tyrptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer 2003; 39: 666–74
   PubMed Web of Science ®Google Scholar
• Reed J. A., McNutt S., Albino A. P. Differential expression of basic fibroblastic growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. ımplications for tumor progression. Am J Pathol 1994; 144: 329–36
   PubMed Web of Science ®Google Scholar